COMPLIANCE An Observational Study of Treatment Compliance and Quality of Life in Patients on Antihypertensive Medication

AstraZeneca

Status: Completed

Conditions: High Blood Pressure

Study type: Observational

Funder types: Industry

Identifiers

NCT01274494

NIS-CME-ATA-2010/1

Details and patient eligibility

About

The aim of this multi-centre survey is to assess treatment adherence and quality of life in a Jordanian and Lebanese population newly diagnosed with hypertension or with uncontrolled essential hypertension being on antihypertensive treatment for at least 6 months.

Enrollment: 1,501 patients

Sex: All

Ages: 21+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients older than 21 years of age
• Patients newly diagnosis with essential hypertension or with hypertension that is uncontrolled after being under the same antihypertensive treatment for at least 6 months (based on the criteria established by the Joint National Committee VII)
• Patients capable of providing an informed consent

Exclusion criteria

• Patients with secondary hypertension
• Pregnant women or nursing mothers
• Patients with acute illnesses or psychiatric diagnosis